ASPHD1 and neoplasm: The relationship between the expression of ASPHD1 and clinicopathological characteristics, including AJCC stage (stage0, I-IV), tumor stage (T0-T4), lymph node stage (N0-3), and immune subtypes (C1-6) was investigated.